Pediatric SARS-CoV-2 Seroprevalence in Arkansas Over the First Year of the COVID-19 Pandemic.

Karl W BoehmeJoshua L KennedyJessica N SnowdenShana M OwensMarianne KouassiRyan L MannAmairani ParedesClaire PuttLaura JamesJing JinRuofei DuCatherine KirkpatrickZeel ModiKatherine CaidSean G YoungNamvar ZohooriAtul KothariBobby L BoyantonJ Craig Forrest

Published in: Journal of the Pediatric Infectious Diseases Society (2022)

By spring 2021, most children in Arkansas were not infected with SARS-CoV-2. With the emergence of SARS-CoV-2 variants, recognition of long-term effects of COVID-19, and the lack of an authorized pediatric SARS-CoV-2 vaccine at the time, these results highlight the importance of including children in SARS-CoV-2 public health, clinical care, and research strategies.

Keyphrases

sars cov
respiratory syndrome coronavirus
public health
young adults
healthcare
gene expression
coronavirus disease
quality improvement